Publicacións nas que colabora con Mar Castellanos Rodrigo (25)

2013

  1. Interleukin-10 facilitates the selection of patients for systemic thrombolysis

    BMC Neurology, Vol. 13

2012

  1. A higher body temperature is associated with haemorrhagic transformation in patients with acute stroke untreated with recombinant tissue-type plasminogen activator (rtPA)

    Clinical Science, Vol. 122, Núm. 3, pp. 113-119

2011

  1. Blood levels of glutamate oxaloacetate transaminase are more strongly associated with good outcome in acute ischaemic stroke than glutamate pyruvate transaminase levels

    Clinical Science, Vol. 121, Núm. 1, pp. 11-17

  2. Early biomarkers of clinical-diffusion mismatch in acute ischemic stroke

    Stroke, Vol. 42, Núm. 10, pp. 2813-2818

  3. High blood glutamate oxaloacetate transaminase levels are associated with good functional outcome in acute ischemic stroke

    Journal of Cerebral Blood Flow and Metabolism, Vol. 31, Núm. 6, pp. 1387-1393

  4. The natural tissue plasminogen activator inhibitor neuroserpin and acute ischaemic stroke outcome

    Thrombosis and Haemostasis, Vol. 105, Núm. 3, pp. 421-429

2010

  1. Association of growth factors with arterial recanalization and clinical outcome in patients with ischemic stroke treated with tPA

    Journal of Thrombosis and Haemostasis, Vol. 8, Núm. 7, pp. 1567-1574

2009

  1. Age determines the effects of blood pressure lowering during the acute phase of ischemic stroke: The TICA study

    Hypertension, Vol. 54, Núm. 4, pp. 769-774

  2. High serum levels of leptin are associated with post-stroke depression

    Psychological Medicine, Vol. 39, Núm. 7, pp. 1201-1209

2008

  1. Marcadores moleculares asociados a signos precoces de isquemia en tomografía computarizada cerebral

    Neurologia, Vol. 23, Núm. 4, pp. 220-225

2007

  1. Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ischemic stroke treated with recombinant tissue plasminogen activator outside clinical trials

    Cerebrovascular Diseases, Vol. 23, Núm. 2-3, pp. 85-90

  2. Statin treatment withdrawal in ischemic stroke: A controlled randomized study

    Neurology, Vol. 69, Núm. 9, pp. 904-910

  3. The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome

    Stroke, Vol. 38, Núm. 10, pp. 2759-2764

2006

  1. A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke

    Journal of Experimental Medicine, Vol. 203, Núm. 3, pp. 711-717

  2. High blood pressure and inflammation are associated with poor prognosis in lacunar infarctions

    Cerebrovascular Diseases, Vol. 22, Núm. 2-3, pp. 123-129

  3. Hyperthermia is a surrogate marker of inflammationmediated cause of brain damage in acute ischaemic stroke

    Journal of Internal Medicine, Vol. 260, Núm. 4, pp. 343-349

  4. Micro- and macroalbuminuria predict hemorrhagic transformation in acute ischemic stroke

    Neurology, Vol. 67, Núm. 7, pp. 1172-1177

  5. New-onset hypertension and inflammatory response/poor outcome in acute ischemic stroke

    Neurology, Vol. 67, Núm. 11, pp. 1973-1978

  6. Response [4]

    Stroke

  7. Vascular protection in brain ischemia

    Cerebrovascular Diseases, Vol. 21, Núm. SUPPL. 2, pp. 21-29